Clinical Trial Update: EMD and/or Bone Substitute for the Treatment of Class II Furcations [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating enamel matrix derivative (EMD) and/or a bone substitute for treatment of Class II furcation defects in periodontal disease; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Disease

Drugs mentioned

• Bone substitute material (bone substitute)
• EMD (Enamel Matrix Derivative) (enamel matrix derivative)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Periodontal Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-03-20